During the past decade, Ottawa Allergy Research Corp conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 14 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ottawa Allergy Research Corp" #1 sponsor was "Aimmune Therapeutics, Inc." with 5 trials, followed by "CSL Behring" with 3 trials sponsored, "Shire" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Circassia Limited" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ottawa Allergy Research Corp" #1 collaborator was "Adiga Life Sciences, Inc." with 2 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator, "Ottawa Allergy Research Corporation" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ottawa Allergy Research Corp" are "Hereditary Angioedema" (5 trials), "Peanut Allergy" (5 trials), "Asthma" (4 trials), "Atopic Dermatitis" (3 trials) and "Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Ottawa Allergy Research Corp" in a lesser frequency.

Most popular intervention types in "Ottawa Allergy Research Corp" are "Biological" (17 trials), "Drug" (13 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "AR101" (4 trials), "Lebrikizumab" (3 trials), "CC-93538" (2 trials) and "CSL312" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ottawa Allergy Research Corp" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Ottawa Allergy Research Corp". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Ottawa Allergy Research Corp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ottawa Allergy Research Corp, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".